Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Technology Industry News Boardwalktech reports fiscal 2026 revenue drop as AI platform build-out completes Boardwalktech's FY26 revenue fell 25% to $3.6 million as cash thinned to $140 thousand, with the completed AI platform now facing a decisive FY27 test. byVenkateshAugust 2, 2026